ALGYO Alarko Gayrimenkul Yatirim Ortakligi A.S.
Alarko Gayrimenkul Yatirim Ortakligi AS is registered in Istanbul and as published in the Turkish Trade Registry Gazette dated August 6, 1996. On October 31, 1996, the Company applied to the Capital Markets Board (CMB or the Board) for a document regarding the registration of shares to be issued by joint stock companies for capital increases and was registered with the Board in accordance with the provisions of the Capital Markets Law with document numbered 1/1552 dated December 13, 1996, and REIT. Its primary activity is to engage in the objectives and subjects outlined in the Capital Markets Board (CMB) regulations regarding real estate investment trusts. Within this scope, the Company engages in investments in real estate, real estate projects, and capital market instruments. Accordingly, the Company complies with CMB regulations and relevant legislation regarding its operating principles, portfolio investment policies, and management limitations. Alarko Gayrimenkul Yatirim Ortakligi A.S. was incorporated in June 6, 1978 in Turkey.…
Industry Peers
REIT - DiversifiedKey Statistics
About Alarko Gayrimenkul Yatirim Ortakligi A.S. (IST: ALGYO)
›
Alarko Gayrimenkul Yatirim Ortakligi A.S. (IST: ALGYO) is listed on Borsa Istanbul, where its shares trade in TRY. It belongs to the REIT - Diversified industry, part of the Real Estate sector, and reports about 13 employees.
The shares were at 2.530 TRY on 19 November 2026, down 39.9% over 52 weeks. Its 52-week range is 2.300 TRY to 8.350 TRY: the price is 69.7% below the high and 10.0% above the low.
Its market capitalisation is 5.13B TRY. It pays a dividend yielding 1.99%, against a median of 5.87% among the dividend payers in that peer group.
Alarko Gayrimenkul Yatirim Ortakligi A.S. reports return on equity of -13.1%, an operating margin of 35.1% and revenue up 3.6% year over year.
Its debt exceeds its cash by 8.12B TRY, a debt-to-equity ratio of 0.27. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.